“U.S. original equipment manufacturers (OEMs), such as Ford, GM, Stellantis, and Tesla, see a lower impact than all other, with Tesla coming out on top. European OEMs have limited spare capacity to increase production at their existing US plants and/or orientate more of that production towards the local US market. Regardless, we question whether OEMs want to upend complex supply chains, especially if the tariff hike proves to be shorter-lived than President Trump presently promises.”
Pharmaceuticals and medical technology
Sheena Berry, healthcare analyst at Quilter Cheviot:
“For now, pharmaceutical products are exempt from reciprocal tariffs, recognising the importance of the medicines. It will likely remain in focus and create a bit of an overhang on companies though. Large pharmaceutical companies have a global footprint with most companies generating 40%-60% of sales in the US. Whilst a number will manufacture a significant portion of drugs in the US for the US, the companies have subsidiaries outside the US which hold the intellectual property and/or manufacture drug products. This is a factor in determining the effective tax rates for these companies."
“Whilst AstraZeneca and GSK are the two UK’s big pharmaceutical companies, less than 10% of sales are generated from the country with both having manufacturing and R&D facilities in the US. As a result, we are likely to see pharmaceutical companies consider additional investment in the US. Recent examples of this include US companies Eli Lilly, Merck and Johnson & Johnson, announcing multi-billion-dollar domestic investments. Whilst pharmaceutical products are currently exempt, companies won’t be spared entirely given they rely on imports for a number of categories that help in the drug development process, but these should be manageable given the low cost of goods in the sector."
“On the other hand, the MedTech and life science sectors will likely feel the most direct impact from tariffs in healthcare. Details from companies will be needed as exposure will be dependent on where products are assembled, finished, and/or sold. There are certain categories within MedTech that may see some benefits from these tariffs given their likely inflationary effect and the fact there is resilient demand for the products. Furthermore, these companies are primarily producing goods in China for the Chinese market. The bigger concern for life sciences companies is if China responds with reciprocal measures, as this sector has a large revenue exposure to China.”
Technology
Ben Barringer, global technology analyst at Quilter Cheviot:
“Initially there is very little primary impact on the tech sector as many of their services are exempt, while the US imports very few semiconductors in their raw form. Where the big problem lies is the knock-on effect of these tariffs. Chips are imported as part of cars and if we are to see demand for cars get hit then this will have an effect on the likes of Infineon."
“Big tech is also not immune. Apple makes 90% of its products in China, with 10% in other Asian countries such as Vietnam and India. These countries are facing the harshest tariffs, so we can expect iPhones and Apple Watches to go up in price, while hitting the profits of the company significantly. Switching production to the US is neither easy, nor cheap."
“The tariffs are also likely to create demand destruction, which means cutbacks on software and cloud spending. Alphabet, will see a double whammy with digital advertising also cut back on in a tougher economic environment – with Meta also being hit in this regard."
“There are very few winners from a tech perspective, but Netflix could be one beneficiary. While the cost of content production will rise, TV is a fairly defensive sector and one of the last things people cut back on. It is enjoying an incredibly dominant position in the entertainment sphere just now and can use this to great effect during any economic downturn.”
Aerospace and defence
Matt Dorset, equity research analyst at Quilter Cheviot:
“Defence names have very little exposure to US tariffs. The US does not import much from Europe, and European names with high exposure to the US largely have production in the US which insulates these businesses from tariff threat. For example, BAE has around a 40% exposure to the US, but this is via US domiciled production."
“On the other hand, commercial aerospace is more exposed given complex global supply chains, with 70% of an aircraft’s parts outsourced to suppliers. In addition, for Airbus, a substantial part of the order backlog is from US airlines – in 2024 about 20% of Airbus commercial jet deliveries were to US customers. Airbus may shoulder some of this cost, but largely it will be passed onto airlines, and Airbus can mitigate this by partially supplying US customers from its US production facility in Mobile, and by prioritising deliveries to non-US customers."
“In the event of retaliatory actions from Europe and other countries, we expect Boeing to suffer more than Airbus due to its higher share of non-US deliveries compared to Airbus's share of US deliveries. There will also be second order impacts on aftermarket players as tariffs hit GDP, this may reduce engine flying hours and in turn aftermarket profits.”
Transport
Dorset said:
“Clearly, in the transport sector both freight forwarders and airlines will be impacted by US tariffs. Tariffs will impact global GDP which in turn will reduce demand for goods, and consequently global trade volumes will be negatively impacted."
“European logistics names have around 20-30% revenue exposure to the Americas of which the US makes up the predominant share – for example, for DSV, exposure to the Americas is 22%. That said, the negative impact of reduced trade volume will be partially offset by the increased opportunity for freight forwarders given increased complexity, which increases the value-add of their offering to clients and may support margin expansion. Airlines will also suffer given the relationship between flight volumes and GDP, as well as potential increased aircraft costs as Airbus passes on tariff costs to airline customers.”
Financials
William Howlett, financials analyst at Quilter Cheviot:
“Within the financials sector, we would see the market infrastructure and exchange stocks (including LSEG and Euronext) as relative beneficiaries as trading volumes increase as the market digests these tariff announcements. These companies also benefit from recurring revenues relating to data subscriptions for example which leads to further resilience in earnings."
“We see the biggest risks among the banks. Fundamentally, banks are levered plays on the economies in which they operate. The outsized tariffs are seen against Asian economies and in that context, it is understandable that the Asian banks (HSBC and Standard Chartered) have sold off the most. We wait to see how central banks react and whether they see these tariffs as a one-off adjustment and therefore are more likely to cut rates to manage the economic fallout. This would create some pressure on net interest income for banks.”
Energy
Maurizio Carulli, global energy analyst at Quilter Cheviot:
“Energy and energy products are exempted from US tariffs. However, in the event US tariffs are maintained long-term and/or a trade war materialises, prolonged lower economic growth would likely occur. This would clearly soften the supply/demand outlook for oil, and Opec might be unlikely to step in at this time, hence the 6% decline on the oil price today."
“Impact of lower GDP growth would be more significant for refiners, though. Furthermore, the possibility of slower investment programs by the oil majors would make oil services companies more negatively affected. It is important to remind that it is possible that US tariffs may be diluted/removed over time and therefore the negative effect on energy companies may prove temporary, but it is simply too early to say. In a lower oil price scenario, energy companies with a strong balance sheet, like Shell and TotalEnergies in Europe and Chevron and ExxonMobil in the US would be more resilient in relative terms.”
Metals and mining
Carulli:
“The previously set 25% US tariff on imported steel and aluminium has been confirmed, while no copper import tariff has been introduced, for the moment, albeit this may change since the US is conducting a strategic review on critical minerals including copper. The indirect negative impact of US tariffs on iron ore may be mitigated by further China economic policy support. It is also important to remember that China represents more than 50% of global metals demand, while Europe 15% and the US only 10%."
“Because of the negative impact on global GDP, industrial production and consequently industrial metals demand, the aggressive US tariffs are a near-term headwind for metals and the mining companies. But long-term fundamentals are unaffected, with secular demand drivers for copper, aluminium and iron ore remaining, as well as supply constraints, particularly for copper.”